- Filed
- Oct 17, 2022 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · Oct 10, 2022 | 119.95M sh |
| Cash And Equivalents | Q2 2023 · Aug 31, 2022 | $1.31K |
| Cash And Equivalents | Q2 2023 · Feb 28, 2022 | $6.89K |
| Cash And Equivalents | Q2 2023 · Aug 31, 2021 | $3.92K |
| Cash And Equivalents | Q2 2023 · Feb 28, 2021 | $4.06K |
| Current Liabilities | Q2 2023 · Aug 31, 2022 | $1.67M |
| Current Liabilities | Q2 2023 · Feb 28, 2022 | $1.56M |
| Total Liabilities | Q2 2023 · Aug 31, 2022 | $1.67M |
| Total Liabilities | Q2 2023 · Feb 28, 2022 | $1.56M |
| Current Assets | Q2 2023 · Aug 31, 2022 | $6.05K |
| Current Assets | Q2 2023 · Feb 28, 2022 | $18.74K |
| Total Assets | Q2 2023 · Aug 31, 2022 | $6.05K |
| Total Assets | Q2 2023 · Feb 28, 2022 | $18.74K |
| Shares Diluted | Q2 2023 · Aug 31, 2021 | 119.95M sh |
| Shares Diluted | Q2 2023 · Aug 31, 2021 | 119.95M sh |
| Operating Cash Flow | Q2 2023 · Aug 31, 2021 | −$26.5K |
| Stockholders Equity | Q2 2023 · Aug 31, 2021 | −$1.42M |
| Stockholders Equity | Q2 2023 · May 31, 2021 | −$1.37M |
| Stockholders Equity | Q2 2023 · Feb 28, 2021 | −$1.31M |
| Eps Diluted | Q2 2023 · Aug 31, 2021 | $0.00 |
| Eps Diluted | Q2 2023 · Aug 31, 2021 | $0.00 |
| Eps Basic | Q2 2023 · Aug 31, 2021 | $0.00 |
| Eps Basic | Q2 2023 · Aug 31, 2021 | $0.00 |
| Sga Expense | Q2 2023 · Aug 31, 2021 | $55.69K |
| Sga Expense | Q2 2023 · Aug 31, 2021 | $109.1K |
| Net Income | Q2 2023 · Aug 31, 2021 | −$55.69K |
| Net Income | Q2 2023 · Aug 31, 2021 | −$109.1K |
| Net Income | Q2 2023 · May 31, 2021 | −$53.41K |
| Operating Income | Q2 2023 · Aug 31, 2021 | −$55.69K |
| Operating Income | Q2 2023 · Aug 31, 2021 | −$109.1K |